Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Arcadia Biosciences (RKDA) Shares Issued (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Shares Issued readings, the most recent being $1000.0 for Q3 2025.

  • On a quarterly basis, Shares Issued fell 75.0% to $1000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $6000.0, a 33.33% decrease, with the full-year FY2025 number at $6000.0, down 33.33% from a year prior.
  • Shares Issued hit $1000.0 in Q3 2025 for Arcadia Biosciences, down from $5000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $750000.0 in Q1 2021 to a low of -$723000.0 in Q2 2021.
  • Median Shares Issued over the past 5 years was $4500.0 (2022), compared with a mean of $6083.3.
  • The widest YoY moves for Shares Issued: up 5257.14% in 2021, down 100.05% in 2021.
  • Arcadia Biosciences' Shares Issued stood at $17000.0 in 2021, then tumbled by 82.35% to $3000.0 in 2022, then surged by 133.33% to $7000.0 in 2023, then crashed by 42.86% to $4000.0 in 2024, then crashed by 75.0% to $1000.0 in 2025.
  • The last three reported values for Shares Issued were $1000.0 (Q3 2025), $5000.0 (Q1 2025), and $4000.0 (Q3 2024) per Business Quant data.